• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

P-glycoproteins: Their function, their absence, and the implications for heartworm prevention

March 2, 2009

We've long known that certain herding breeds, especially collies, have a sensitivity to ivermectin. The cause of this sensitivity is a deletion mutation in the ABCB1 gene (formerly known as the multidrug resistant gene, or MDR1).

Untitled Document

We've long known that certain herding breeds, especially collies, have a sensitivity to ivermectin. The cause of this sensitivity is a deletion mutation in the ABCB1 gene (formerly known as the multidrug resistant gene, or MDR1). About two-thirds of collies have at least one mutant allele in this gene. Other breeds with this mutation are shelties, Australian shepherds, and Old English sheepdogs, although not as high of a percentage of these breeds are affected. The unmutated gene produces p-glycoprotein, which decreases exposure to administered, potentially toxic xenobiotics, including many chemotherapeutic drugs (e.g. vinblastine, doxorubicin) and macrocyclic lactones (e.g. ivermectin, selamectin, moxidectin, milbemycin). An article in Veterinary Parasitology recently reviewed the association between macrocyclic lactones and the ABCB1 gene. In essence, p-glycoprotein limits the penetration of these drugs across the blood-brain barrier, inhibits their absorption in the gastrointestinal tract, and promotes their biliary and renal excretion. In dogs with the genetic mutation, p-glycoprotein is not present, so the dogs are much more prone to toxicosis.

From a practical perspective, the author emphasized that all current heartworm preventives that contain ivermectin, selamectin, moxidectin, or milbemycin given at their recommended dosages are completely safe in dogs with the mutation. One situation that may be a risk, however, is when ivermectin formulated for cattle is used to treat a dog because it is cheaper. Protocols for these products listed on various lay Web sites would result in dosages above the toxic level in dogs with the genetic mutation. Also, some drugs can inhibit p-glycoprotein, so even in unaffected dogs, the administration of these drugs in conjunction with p-glycoprotein substrates such as macrocyclic lactones can result in toxicity. While monthly heartworm preventives formulated for dogs that contain macrocyclic lactones are safe when given at the correct dosage, other drugs, such as chemotherapeutic agents, are more of a concern for toxicosis. In these cases, genetic testing can reveal whether a dog has the mutation and whether certain drugs should be avoided to prevent toxicosis.

Advertisement

 

Mealey KL. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics. Vet Parasitol 2008;158:215-222.

Link to abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TD7-4TCYCKB-9&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=4a845f2b52a2d7b0e422c8c1a2930d44

Related Content:

Clinical
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman

Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement